Literature DB >> 25445436

Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice.

Ho Sung Lee1, Yunsung Nam1, Yoon Hee Chung2, Hak Rim Kim3, Eon Sub Park4, Su Jin Chung1, Jung Hyo Kim5, Uy Dong Sohn5, Hyoung-Chun Kim6, Keon Woong Oh7, Ji Hoon Jeong8.   

Abstract

AIMS: Soybean-derived PC is an essential cell membrane phospholipid that is composed of unsaturated fatty acids, including oleic acid. The present study aimed to evaluate the potential alleviation effects of soybean PC on high fat diet (HFD)-induced obesity and its related complications. MAIN
METHODS: We fed C57BL/6 mice a HFD for 12 weeks and administered PC orally for 8 or 12 weeks at different doses. At the end of the experiment, blood was prepared for biochemical analysis and leptin ELISA. Aorta, epididymal and mesenteric fat and liver were removed surgically, weighed and observed for histological or immunohistochemical changes. KEY
FINDINGS: PC significantly prevented body weight gain and lipid accumulation and alleviated hyperlipidemia by decreasing triglyceride (TG) and total cholesterol (TC) levels and the atherogenic index in serum or by increasing the HDL/TC ratio. Aortic apoE expression and serum leptin levels were suppressed by PC treatment in the HFD-induced obese mouse model. Elevated serum aspartate aminotransferase and alanine aminotransferase levels in HFD-fed mice were decreased in the PC groups. PC treatment significantly decreased HFD-induced liver weight and hepatic lipid accumulation. SIGNIFICANCE: PC treatment alleviated HFD-induced obese status and obesity-related complications such as hyperlipidemic changes that induce cardiovascular disease and NAFLD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apo-E; Dyslipidemia; High-fat diet; Non-alcoholic fatty liver disease; Obesity; Phosphatidylcholine

Mesh:

Substances:

Year:  2014        PMID: 25445436     DOI: 10.1016/j.lfs.2014.09.027

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  27 in total

1.  An experimental model for hypertensive crises emergencies: Long-term high-fat diet followed by acute vasoconstriction stress on spontaneously hypertensive rats.

Authors:  Hong Liu; Wei-Wei Su; Chao-Feng Long; Wei-Jian Zhang; Pei-Bo Li; Zhong Wu; Yin-Yin Liao; Xuan Zeng; Tao-Bin Chen; Yu-Ying Zheng; Zeng-Hao Yan; Cong Bi; Hong-Liang Yao
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-14

2.  Endoplasmic reticulum stress and calcium imbalance are involved in cadmium-induced lipid aberrancy in Saccharomyces cerevisiae.

Authors:  Selvaraj Rajakumar; Nagaraj Bhanupriya; Chidambaram Ravi; Vasanthi Nachiappan
Journal:  Cell Stress Chaperones       Date:  2016-06-25       Impact factor: 3.667

Review 3.  Lipid droplets and liver disease: from basic biology to clinical implications.

Authors:  Nina L Gluchowski; Michel Becuwe; Tobias C Walther; Robert V Farese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-04-21       Impact factor: 46.802

Review 4.  Adaptive and maladaptive roles of lipid droplets in health and disease.

Authors:  Jeffrey D Pressly; Margaret Z Gurumani; Javier T Varona Santos; Alessia Fornoni; Sandra Merscher; Hassan Al-Ali
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-02       Impact factor: 4.249

5.  Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS).

Authors:  Justin M Conley; Christy S Lambright; Nicola Evans; Elizabeth Medlock-Kakaley; Donna Hill; James McCord; Mark J Strynar; Leah C Wehmas; Susan Hester; Denise K MacMillan; L Earl Gray
Journal:  Environ Int       Date:  2021-12-22       Impact factor: 9.621

6.  Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.

Authors:  Agnieszka Zwolak; Agnieszka Szuster-Ciesielska; Jadwiga Daniluk; Olga Słabczyńska; Martyna Kandefer-Szerszeń
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

7.  Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

Authors:  Rong Zhang; Keran Cheng; Shizan Xu; Sainan Li; Yuqing Zhou; Shunfeng Zhou; Rui Kong; Linqiang Li; Jingjing Li; Jiao Feng; Liwei Wu; Tong Liu; Yujing Xia; Jie Lu; Chuanyong Guo; Yingqun Zhou
Journal:  Gastroenterol Res Pract       Date:  2017-01-04       Impact factor: 2.260

8.  Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.

Authors:  Eun-Young Park; Hojung Choi; Ji-Young Yoon; In-Young Lee; Youngwan Seo; Hong-Seop Moon; Jong-Hee Hwang; Hee-Sook Jun
Journal:  Mar Drugs       Date:  2015-11-12       Impact factor: 5.118

9.  Fecal metabolome of the Hadza hunter-gatherers: a host-microbiome integrative view.

Authors:  Silvia Turroni; Jessica Fiori; Simone Rampelli; Stephanie L Schnorr; Clarissa Consolandi; Monica Barone; Elena Biagi; Flaminia Fanelli; Marco Mezzullo; Alyssa N Crittenden; Amanda G Henry; Patrizia Brigidi; Marco Candela
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

10.  Nanosized soy phytosome-based thermogel as topical anti-obesity formulation: an approach for acceptable level of evidence of an effective novel herbal weight loss product.

Authors:  Shahira F El-Menshawe; Adel A Ali; Mohamed A Rabeh; Nermeen M Khalil
Journal:  Int J Nanomedicine       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.